KEGG pathway analysis demonstrated that hub genes were mainly associated with the p53 signaling pathway, EGFR tyrosine kinase inhibitor resistance, colorectal cancer, ECM-receptor interaction, gap junction, FoxO signaling pathway, apoptosis, bladder cancer, and gastric cancer (Fig 5E). This evidence concerns the gene TP53 and urinary bladder carcinoma.